Avicanna Inc.
Symbol:
TSX: AVCN
OTCQX: AVCNF
Market Cap:
47M
Purpose
Raise Awareness, Open Market Buying
Sector:
Pharmaceutical
Summary:
- Commercial stage biopharmaceutical company with 314% Y-Y growth in revenues in over 20+ countries
- First pharmaceutical drug approval Q1 2024 for catastrophic epilepsy conditions
- Extensive pipeline of pharmaceutical drugs addressing dermatological, neurological and pain disorders
- Recently acquired medical cannabis by Shopper’s drug mart